FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098330 [Registered on: 02/12/2025] Trial Registered Prospectively
Last Modified On: 16/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Ayurvedic Decoction Enema in the management of Irritable Bowel Syndrome. 
Scientific Title of Study   Clinical Study to Evaluate the Effect of Shampakadi Niruha Basti in Grahani w.s.r. to Irritable Bowel Syndrome(IBS). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yasir Sameer Dabir 
Designation  PG Scholar 
Affiliation  College of Ayurved, Bharati Vidyapeeth, Pune 
Address  Department of Panchakarma, College of Ayurved, Bharati Vidyapeeth (Deemed to be University), Dhankawadi, Pune

Pune
MAHARASHTRA
411043
India 
Phone  7498590067  
Fax    
Email  yasir.dabir-ayurved@bvp.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santosh E Chavan 
Designation  Professor and Head of Department, Panchakarma 
Affiliation  College Of Ayurved, Bharati Vidyapeeth, Pune 
Address  Department of Panchakarma, College of Ayurved, Bharati Vidyapeeth (Deemed to be University), Dhankawadi, Pune

Pune
MAHARASHTRA
411043
India 
Phone  9822249807  
Fax    
Email  santosh.chavan@bharatividyapeeth.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Santosh E Chavan 
Designation  Professor and Head of Department, Panchakarma 
Affiliation  College Of Ayurved, Bharati Vidyapeeth, Pune 
Address  Department of Panchakarma, College of Ayurved, Bharati Vidyapeeth (Deemed to be University), Dhankawadi, Pune

Pune
MAHARASHTRA
411043
India 
Phone  9822249807  
Fax    
Email  santosh.chavan@bharatividyapeeth.edu  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth(Deemed to be University), Dhanakawadi, 411043, Pune, Maharashtra, India 
 
Primary Sponsor  
Name  Dr Yasir Sameer Dabir 
Address  Department of Panchakarma, College of Ayurved and Hospital, Bharati Vidyapeeth (Deemed to be University), Dhanakawadi, 411043, Pune, Maharashtra, India  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yasir Sameer Dabir  College of Ayurved and Hospital, Bharati Vidyapeeth Deemed to be University  Bharati vidyapeeth (Deemed to be) University, Bharati Ayurved Hospital, Department Of Panchakarma OPD No 21, Dhankawadi, Katraj, Pune
Pune
MAHARASHTRA 
7498590067

yasir.dabir-ayurved@bvp.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BHARATI VIDYAPEETH (DEEMED TO BE UNIVERSITY), PUNE (INDIA) COLLEGE OF AYURVED PUNE-SATARA ROAD, PUNE 411 043. INSTITUTIONAL ETHICS COMMITTEE BV(DU)COA IEC   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K582||Mixed irritable bowel syndrome. Ayurveda Condition: GRAHANIDOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Sushruta Samhita Chikitsasthan, Procedure details: Murchita Tila Tail Anuvasan Basti & Shampakadi Niruha Basti, by Yoga Basti Krama.)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having classical signs and symptoms of Muhur-Baddha Muhur-Drava mala pravrutti,
Picchila Malapravrutti, Aruchi, Adhman, Tikta Amlodgar, Antrakujan and Balakshay.
Awastha of Grahani in which there is Agnimandya and Purish, Mutra and Maruta Avarodh.
Diagnosis with active Irritable Bowel Syndrome symptoms as indicated by a score between (75 - 299
on IBS SEVERITY SCORING SYSTEM)
Patient Arha for Basti Karma. 
 
ExclusionCriteria 
Details  More than 3 years chronicity of Grahani.
Known cases of systemic diseases like Hypertension
Cases of Anorectal diseases and Colon Resection Surgeries
Patients Anarha for Basti karma
Pregnant women and lactating mothers.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcomes will include improvement in the clinical features of Grahani.
Symptom Score Reduction :
Muhurbaddha Muhurdrava Mala (Episode of hard & loose stools)
Adhman (Distention of Abdomen)
Balakshaya (Weakness)
Picchila Malapravrutti (Passing mucus in stool)
Aruchi (Anorexia) Tikta-Amlodgara (Iron pungent odour burps)
Antrakujana (Gurgling sound in abdomen)  
Base Line, 9th Day, 30th Day, 45th Day 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary assessments may include standardized tools such as the Gastrointestinal Symptoms
Rating Scale (GSRS), IBS Severity Scoring System (IBS-SSS) and Bristol Stool Chart to
correlate with modern GI symptomatology. 
Base Line, 9th Day, 30th Day, 45th Day 
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  15/12/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Grahani is having NAMC Code ICD-601 EB-7(1) (disorders of lower Gastro Interstinal tract). Grahani is a chronic gastrointestinal disorder described in Ayurveda under the spectrum of Ashta Mahagada (major diseases) by Acharya Vagbhat. It is primarily a dysfunction of Agni (digestive fire), especially Jatharagni, leading to improper digestion and assimilation of food. The seat of Grahani is considered to be the Grahani organ itself, located anatomically near the Amashaya and Pakvashaya, and physiologically responsible for the retention and release of digested food. According to Acharya Charak, Grahani is a disease which is originated from Mandagni (weak digestion), resulting in the formation of Ama (toxic undigested metabolites), which causes symptoms such as Muhur-Baddha Muhur-Drava, Picchila Mala pravrutti, Aruchi, Asyavairasya, Adhman, Antrakujan, Balakshay and Loha-Amagandhi-Tikta-Amla Udgar(2). It can be correlated with conditions such as irritable bowel syndrome (IBS) in modern medicine. The clinical features of Grahani closely resembles to Irritable Bowel Syndrome (IBS) ICD Code- K 58(1), a functional gastrointestinal disorder marked by abdominal pain or discomfort along with altered bowel habits, despite the absence of any detectable structural abnormalities. Since there are no definitive diagnostic tests for IBS, its diagnosis primarily depends on clinical symptoms by GSRS and IBS Score. IBS is among the most frequently observed conditions in medical practice, yet it remains poorly understood. Globally, approximately 10–20% of adolescents and adults exhibit symptoms consistent with IBS, with a higher incidence reported in females. The severity of symptoms may vary widely, often leading to a considerable decline in quality of life and increased healthcare expenses. Current treatment approaches in modern medicine mostly offer symptomatic relief and may sometimes lead to adverse effects. This creates a promising opportunity for Ayurveda as main line of treatment, to explore more effective and holistic treatment options for IBS. Acharya Sushruta mentioned Shampakadi Basti, a type of Asthapan Basti (decoction-based enema), is mentioned in Ayurvedic texts for its Deepana-Pachana, Vata-Kapha shamaka, and Grahani-hara actions. Niruha Basti is considered one of the most effective therapeutic procedures in Panchakarma for Pakvashaya gata Vata and Grahani disorders.
The Study will be consisting of one Group as per the inclusion criteria that group will receive Yoga Basti Krama using Shampakadi Niruha Basti and Murchita Tila Taila Anuvasana Basti for 8 days.
 
Close